Please login to the form below

Not currently logged in


This page shows the latest presbyopia news and features for those working in and with pharma, biotech and healthcare.

Novartis buys two firms in pre-Christmas shopping spree

Novartis buys two firms in pre-Christmas shopping spree

The takeover of Encore gives Novartis rights to EV06 (lipoic acid choline ester), a disease-modifying treatment for age-related loss of near distance vision (presbyopia) that can be delivered in ... Presbyopia affects 80% of people aged over 45 and makes

Latest news

  • FDA approves wireless contact lens sensor FDA approves wireless contact lens sensor

    In eye care Novartis has licensed the rights to Google's smart lens technology and is developing it for use in diabetes and presbyopia, with clinical trials due to begin later

  • You're in good hands You're in good hands

    Are we throwing expensive presbyopia-correcting intraocular lenses for cataract patients into this basket of goods?

  • Novartis buys rights to Google's 'smart lens' technology Novartis buys rights to Google's 'smart lens' technology

    Pharma company's eye unit Alcon will focus on uses in diabetes and presbyopia.  . ... The other is to help people with presbyopia – age-related long-sightedness that makes it more difficult to focus on objects that are near.  .

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....